A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Clinical trial NCT06676007 · RECRUITING

Trial details

NCT number: NCT06676007
Sponsor: Sichuan Provincial People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

IgA Nephropathy (IgAN)Early Initial Therapy

Start date: 2024-10-30
Primary completion: 2026-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.